




Afatinib, also known by its trade names Gilotrif and Afatinib, is a targeted therapy drug primarily used in the treatment of non-small cell lung cancer (NSCLC), particularly in cases where the cancer has a specific genetic mutation known as an EGFR mutation. This medication works by inhibiting the activity of the EGFR protein, which can help slow down or stop the growth and spread of cancer cells. The cost of Afatinib varies significantly depending on the manufacturer and the country of purchase.
The price of Afatinib can vary widely based on several factors, including the manufacturer, the country of purchase, and the availability of generic versions. Below, we provide a detailed breakdown of the prices for different manufacturers:
Selangor, Malaysia (Beximco Pharmaceuticals):
The price for a box of Afatinib from Beximco Pharmaceuticals, containing 30 tablets of 40mg each, is approximately $313 USD. This is one of the more affordable options available on the market.
Bangladesh (Beximco Pharmaceuticals):
In Bangladesh, the same 30-tablet box of Afatinib from Beximco Pharmaceuticals is priced at around $313 USD. The consistency in pricing between Malaysia and Bangladesh suggests that the manufacturing costs and distribution networks are similar in these regions.
India (Natco Pharma):
Another significant player in the market is Natco Pharma from India, which offers a 28-tablet box of Afatinib at a slightly higher price of $103 USD. This makes it one of the most accessible options for patients in India and surrounding regions.
Lao Luexius (Laos):
Lao Luexius, a pharmaceutical company based in Laos, provides a 30-tablet box of Afatinib at a highly competitive price of $81 USD. This makes it one of the most affordable options for patients seeking this medication.
Understanding the price variations can help patients and healthcare providers make informed decisions about the most cost-effective and accessible options for treatment.
While the cost of Afatinib is an important factor, equally crucial are the guidelines and precautions that patients should follow when using this medication. Proper usage and adherence to medical advice can maximize the effectiveness of the treatment and minimize potential side effects.
Storage Conditions:
Afatinib should be stored at room temperature, away from moisture and direct sunlight. It is important to keep the medication in its original packaging until it is ready to be taken. This helps maintain the integrity and efficacy of the drug.
Handling Precautions:
Patients should avoid touching the tablets with wet hands, as this can affect their stability. If a tablet is accidentally broken or crushed, it should not be used, and the patient should contact their healthcare provider for further instructions.
Recommended Dosage:
The standard dosage of Afatinib is 40mg once daily, taken orally. Patients should take the medication at the same time each day to maintain consistent levels in the body. It is recommended to take Afatinib with food to reduce the risk of gastrointestinal side effects.
Missed Doses:
If a dose is missed, it should be taken as soon as the patient remembers. However, if it is close to the time for the next dose, the missed dose should be skipped, and the regular dosing schedule should be resumed. Double doses should not be taken to make up for a missed dose.
Common Side Effects:
Common side effects of Afatinib include diarrhea, rash, and mouth sores. These side effects are generally manageable with appropriate care and medication. Patients should report any severe or persistent side effects to their healthcare provider.
Regular Monitoring:
Patients taking Afatinib should undergo regular monitoring, including blood tests and imaging studies, to assess the effectiveness of the treatment and to monitor for any potential complications. Regular check-ups with a healthcare provider are essential to ensure the best possible outcomes.
By following these guidelines and working closely with healthcare providers, patients can effectively manage their treatment with Afatinib and improve their quality of life during the course of their illness.
免费咨询电话
400-001-2811